Osage University Partners has returned to back the cancer and inflammatory drug developer based on research from multiple universities.
Avego BioScience Capital, Monashee Investment…
Osage University Partners has returned to back the cancer and inflammatory drug developer based on research from multiple universities.
The students face obstacles in raising money for the planned $1m venture fund.
The global drinks brand invests in early-stage startups and academic research where it can get closely involved in testing out the technologies at its operations.
The UK university has set up physical presence in San Francisco to be closer to US investors and companies it seeks to partner with.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.